Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

908 Devices Inc

MASS
Current price
2.38 USD +0.04 USD (+1.71%)
Last closed 2.92 USD
ISIN US65443P1021
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 123 724 776 USD
Yield for 12 month -63.33 %
1Y
3Y
5Y
10Y
15Y
MASS
21.11.2021 - 28.11.2021

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts. Address: 645 Summer Street, Boston, MA, United States, 02210

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

14 USD

P/E ratio

Dividend Yield

Current Year

+50 229 000 USD

Last Year

+46 852 000 USD

Current Quarter

+14 047 000 USD

Last Quarter

+9 991 000 USD

Current Year

+23 366 000 USD

Last Year

+26 023 000 USD

Current Quarter

+7 255 000 USD

Last Quarter

+3 895 000 USD

Key Figures MASS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -42 304 000 USD
Operating Margin TTM -96.53 %
PE Ratio
Return On Assets TTM -13.49 %
PEG Ratio
Return On Equity TTM -22.96 %
Wall Street Target Price 14 USD
Revenue TTM 52 686 000 USD
Book Value 4.52 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 16.1 %
Dividend Yield
Gross Profit TTM 26 023 000 USD
Earnings per share -1.15 USD
Diluted Eps TTM -1.15 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -72.1 %

Dividend Analytics MASS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History MASS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation MASS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.9857
Price Sales TTM 2.3483
Enterprise Value EBITDA -3.1531
Price Book MRQ 0.7913

Financials MASS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MASS

For 52 weeks

3.13 USD 12.51 USD
50 Day MA 3.52 USD
Shares Short Prior Month 1 352 467
200 Day MA 5.38 USD
Short Ratio 9.41
Shares Short 1 370 405
Short Percent 6.29 %